对比增强超声相较于B型超声在肝细胞腺瘤亚型分型中的有限附加价值
纳入33例患者44个经病理证实并分型的肝细胞腺瘤(29个炎症型、15个HNF1-α失活型),由两名放射科医生独立回顾B型超声与对比增强超声特征。多数对比增强超声特征尤其是增强模式在亚型间无显著差异;B型超声上病灶高回声、均匀且无明确肝脂肪变联合应用可能有助于区分HNF1-α失活型与炎症型。
要点
- HNF1-α失活型肝细胞腺瘤在B型超声上多表现为均匀高回声(14/15,93%),与炎症型差异有统计学意义(p=0.001)。
- 中度或重度肝脂肪变仅见于炎症型肝细胞腺瘤(12/29,41%)(p=0.001)。
- B型超声上病灶均匀且高回声时,识别HNF1-α失活型的特异度为100%;若肝有明显脂肪变且不具备上述两特征,排除HNF1-α失活型的敏感度为100%。
关键影像表现/征象
- 炎症型肝细胞腺瘤在B型超声上多表现为低回声(23/29,79%)或等回声(4/29,14%),其中12个(41%)表现不均匀。
- HNF1-α失活型除1个外均表现为均匀高回声(14/15,93%)(p=0.001)。
- 中度或重度肝脂肪变仅见于炎症型(12/29,41%)(p=0.001)。
- 对比增强超声动脉期高增强见于炎症型27/29(93%)与HNF1-α失活型14/15(93%)(p=0.98)。
- 廓清见于炎症型6/29(21%)与HNF1-α失活型1/15(7%)(p=0.27);门脉期及延迟期均匀者分别为炎症型23/29(79%)与HNF1-α失活型15/15(100%)(p=0.04)。
诊断标准与关键数值
- B型超声上病灶均匀且高回声时,识别HNF1-α失活型的特异度为100%。
- 肝有明显脂肪变且不具备病灶高回声与均匀这两项特征时,排除HNF1-α失活型的敏感度为100%。
临床应用与阅片要点
- 在对比增强超声怀疑肝细胞腺瘤时,应结合B型超声特征进行亚型判断。
- 病灶高回声、均匀且无明确肝脂肪变的组合可能有助于区分HNF1-α失活型与炎症型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the features of hepatocellular adenoma subtypes (HCAs) in B-mode and contrast-enhanced ultrasound (CEUS).
METHOD: Thirty-three patients (31 women [94 %] and two men [6%], median age [Q1-Q3] 43.5 years old [35-51]) with 44 pathologically proven and subtyped HCAs (including 29 inflammatory HCAs [I-HCA] and 15 HNF1-α inactivated HCAs [H-HCA]) who underwent CEUS were included. The features of HCA on B-mode and CEUS were independently reviewed by two radiologists and compared between HCA subtypes.
RESULTS: I-HCAs were mostly hypoechoic (23/29, 79 %) or isoechoic (4/29, 14 %) with B-mode. Twelve of them (41 %) were heterogeneous. All H-HCAs except one demonstrated homogeneous hyperechogenicity (93 %) (p = 0.001). Moderate or marked liver steatosis was only observed in I-HCAs (12/29, 41 %) (p = 0.001). Arterial hyperenhancement was observed on CEUS in 27/29 (93 %) I-HCAs and in 14/15 (93 %) H-HCAs (p=0.98). Washout was present in 6/29 (21 %) I-HCAs and 1/15 (7%) H-HCAs (p=0.27). A total of 23/29 (79 %) I-HCAs and 15/15 (100 %) HCAs were homogeneous on portal and delayed phase acquisitions (p=0.04). The specificity for identifying an H-HCA was 100 % when the lesion was homogeneous and hyperechoic on B-mode, and the sensibility to rule out an H-HCA was 100 % if neither of these two features was present in a liver with obvious steatosis.
CONCLUSIONS: Most CEUS features, especially enhancement patterns, do not significantly differ between HCA subtypes. When HCA is suspected on CEUS, B-mode features should be considered, and a combination of lesion hyperechogenicity, homogeneity and the absence of obvious liver steatosis may be useful to distinguish H-HCAs from I-HCAs.
引用
- Gregory J, Paisant A, Paulatto L, et al. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas. Eur J Radiol. 2020. PMID: 32361381. doi:10.1016/j.ejrad.2020.109027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。